{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:50:07Z","timestamp":1782309007887,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Capital\u2019s Funds for Health Improvement and Research of China","award":["CFH 2020-1-6041"],"award-info":[{"award-number":["CFH 2020-1-6041"]}]},{"name":"the Young Investigator Training Program of The First Affiliated Hospital of Nanchang University","award":["YFYPY202572"],"award-info":[{"award-number":["YFYPY202572"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"DOI":"10.1007\/s00535-026-02461-x","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:28:41Z","timestamp":1782307721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia-mediated chromatin accessibility reprogramming of CA9 induces treatment resistance in colorectal mucinous adenocarcinoma"],"prefix":"10.1007","author":[{"given":"An","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2461_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"2461_CR2","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v13.i12.1567","author":"A Huang","year":"2021","unstructured":"Huang A, Yang Y, Shi JY, Li YK, Xu JX, Cheng Y, et al. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer. World J Gastrointest Surg. 2021. https:\/\/doi.org\/10.4240\/wjgs.v13.i12.1567.","journal-title":"World J Gastrointest Surg"},{"key":"2461_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.140","author":"N Hugen","year":"2016","unstructured":"Hugen N, Brown G, Glynne-Jones R, de Wilt JH. Nagtegaal ID Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol. 2016. https:\/\/doi.org\/10.1038\/nrclinonc.2015.140.","journal-title":"Nat Rev Clin Oncol"},{"key":"2461_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01684-4","author":"T Shang","year":"2025","unstructured":"Shang T, Jia Z, Li J, Cao H, Xu H, Cong L, et al. Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance. J Hematol Oncol. 2025. https:\/\/doi.org\/10.1186\/s13045-025-01684-4.","journal-title":"J Hematol Oncol"},{"key":"2461_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.10.002","author":"M Ivan","year":"2022","unstructured":"Ivan M, Fishel ML, Tudoran OM, Pollok KE, Wu X. Smith PJ Hypoxia signaling: Challenges and opportunities for cancer therapy. Semin Cancer Biol. 2022. https:\/\/doi.org\/10.1016\/j.semcancer.2021.10.002.","journal-title":"Semin Cancer Biol"},{"key":"2461_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/jci159839","author":"EE Wicks","year":"2022","unstructured":"Wicks EE. Semenza GL Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/jci159839.","journal-title":"J Clin Invest"},{"key":"2461_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.12.020","author":"F Paredes","year":"2021","unstructured":"Paredes F, Williams HC. San Martin A Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.020.","journal-title":"Cancer Lett"},{"key":"2461_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103286","author":"Z Lin","year":"2024","unstructured":"Lin Z, Yang S, Qiu Q, Cui G, Zhang Y, Yao M, et al. Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer. Redox Biol. 2024. https:\/\/doi.org\/10.1016\/j.redox.2024.103286.","journal-title":"Redox Biol"},{"key":"2461_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100787","author":"J Kopecka","year":"2021","unstructured":"Kopecka J, Salaroglio IC, Perez-Ruiz E, Sarmento-Ribeiro AB, Saponara S, De Las RJ, et al. Hypoxia as a driver of resistance to immunotherapy. Drug Resist Updat. 2021. https:\/\/doi.org\/10.1016\/j.drup.2021.100787.","journal-title":"Drug Resist Updat"},{"key":"2461_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(01)00498-0","author":"A Gratchev","year":"2001","unstructured":"Gratchev A, Siedow A, Bumke-Vogt C, Hummel M, Foss HD, Hanski ML, et al. Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation. Cancer Lett. 2001. https:\/\/doi.org\/10.1016\/s0304-3835(01)00498-0.","journal-title":"Cancer Lett"},{"key":"2461_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw3835","author":"AP Feinberg","year":"2023","unstructured":"Feinberg AP. Levchenko A Epigenetics as a mediator of plasticity in cancer. Science. 2023. https:\/\/doi.org\/10.1126\/science.aaw3835.","journal-title":"Science"},{"key":"2461_CR12","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21765","author":"V Davalos","year":"2023","unstructured":"Davalos V. Esteller M Cancer epigenetics in clinical practice. CA Cancer J Clin. 2023. https:\/\/doi.org\/10.3322\/caac.21765.","journal-title":"CA Cancer J Clin"},{"key":"2461_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2016.93","author":"PA Jones","year":"2016","unstructured":"Jones PA, Issa JP. Baylin S Targeting the cancer epigenome for therapy. Nat Rev Genet. 2016. https:\/\/doi.org\/10.1038\/nrg.2016.93.","journal-title":"Nat Rev Genet"},{"key":"2461_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-018-0089-8","author":"SL Klemm","year":"2019","unstructured":"Klemm SL, Shipony Z. Greenleaf WJ Chromatin accessibility and the regulatory epigenome. Nat Rev Genet. 2019. https:\/\/doi.org\/10.1038\/s41576-018-0089-8.","journal-title":"Nat Rev Genet"},{"key":"2461_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02030-9","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q, et al. Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-02030-9.","journal-title":"Signal Transduct Target Ther"},{"key":"2461_CR16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1805035","author":"SE Bates","year":"2020","unstructured":"Bates SE. Epigenetic therapies for cancer. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMra1805035.","journal-title":"N Engl J Med"},{"key":"2461_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1335678","author":"A Huang","year":"2024","unstructured":"Huang A, Yang Y, Sun Z, Hong H, Chen J, Gao Z, et al. Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from China. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1335678.","journal-title":"Front Oncol"},{"key":"2461_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-019-0164-5","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P. Kroemer G The molecular machinery of regulated cell death. Cell Res. 2019. https:\/\/doi.org\/10.1038\/s41422-019-0164-5.","journal-title":"Cell Res"},{"key":"2461_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106936","author":"Y Zou","year":"2022","unstructured":"Zou Y, Xie J, Zheng S, Liu W, Tang Y, Tian W, et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int J Surg. 2022. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106936.","journal-title":"Int J Surg"},{"key":"2461_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biology11020231","author":"Y Huang","year":"2022","unstructured":"Huang Y, Huang H, Wang Y, Liu H. Huang Y 5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma. Biology (Basel). 2022. https:\/\/doi.org\/10.3390\/biology11020231.","journal-title":"Biology (Basel)"},{"key":"2461_CR21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202500293RR","author":"M Sang","year":"2025","unstructured":"Sang M, Huang Q, Mao M, Yan H, Ge J, Zhang R, et al. Characterization of m6A-Related Genes in Tumor-Associated Macrophages for Prognosis, Immunotherapy, and Drug Prediction in Lung Adenocarcinomas Based on Machine Learning Algorithms. Faseb j. 2025. https:\/\/doi.org\/10.1096\/fj.202500293RR.","journal-title":"Faseb j"},{"key":"2461_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22209","author":"C Xing","year":"2023","unstructured":"Xing C, Zhu S, Yan W, Zhu H, Huang Z, Zhao Y, et al. Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma. Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22209.","journal-title":"Heliyon"},{"key":"2461_CR23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-10-4261","author":"Y Lou","year":"2011","unstructured":"Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res. 2011. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-4261.","journal-title":"Cancer Res"},{"key":"2461_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.550","author":"FE Lock","year":"2013","unstructured":"Lock FE, McDonald PC, Lou Y, Serrano I, Chafe SC, Ostlund C, et al. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene. 2013. https:\/\/doi.org\/10.1038\/onc.2012.550.","journal-title":"Oncogene"},{"key":"2461_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav1898","author":"MR Corces","year":"2018","unstructured":"Corces MR, Granja JM, Shams S, Louie BH, Seoane JA, Zhou W, et al. The chromatin accessibility landscape of primary human cancers. Science. 2018. https:\/\/doi.org\/10.1126\/science.aav1898.","journal-title":"Science"},{"key":"2461_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05391-5","author":"A Huang","year":"2024","unstructured":"Huang A, Sun Z, Hong H, Yang Y, Chen J, Gao Z, et al. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer. J Transl Med. 2024. https:\/\/doi.org\/10.1186\/s12967-024-05391-5.","journal-title":"J Transl Med"},{"key":"2461_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3064","author":"WR Wilson","year":"2011","unstructured":"Wilson WR. Hay MP Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011. https:\/\/doi.org\/10.1038\/nrc3064.","journal-title":"Nat Rev Cancer"},{"key":"2461_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj0364","author":"SC Chafe","year":"2021","unstructured":"Chafe SC, Vizeacoumar FS, Venkateswaran G, Nemirovsky O, Awrey S, Brown WS, et al. Genome-wide synthetic lethal screen unveils novel CAIX-NFS1\/xCT axis as a targetable vulnerability in hypoxic solid tumors. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abj0364.","journal-title":"Sci Adv"},{"key":"2461_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00435-0","author":"EC Cheung","year":"2022","unstructured":"Cheung EC. Vousden KH The role of ROS in tumour development and progression. Nat Rev Cancer. 2022. https:\/\/doi.org\/10.1038\/s41568-021-00435-0.","journal-title":"Nat Rev Cancer"},{"key":"2461_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-019-0361-0","author":"C Luo","year":"2019","unstructured":"Luo C, Cen S, Ding G. Wu W Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond). 2019. https:\/\/doi.org\/10.1186\/s40880-019-0361-0.","journal-title":"Cancer Commun (Lond)"},{"key":"2461_CR31","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2023.03.01","author":"Association NHCOTPsROCSOOCM National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China","year":"2023","unstructured":"Association NHCOTPsROCSOOCM National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China. National health commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version). Chin J Cancer Res. 2023. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2023.03.01.","journal-title":"Chin J Cancer Res"},{"key":"2461_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.86655","author":"E Budinsk\u00e1","year":"2023","unstructured":"Budinsk\u00e1 E, Hriv\u0148\u00e1kov\u00e1 M, Ivkovic TC, Madrzyk M, Nenutil R, Bencsikov\u00e1 B, et al. Molecular portraits of colorectal cancer morphological regions. Elife. 2023. https:\/\/doi.org\/10.7554\/eLife.86655.","journal-title":"Elife"},{"key":"2461_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1517-0","author":"MC Bosco","year":"2020","unstructured":"Bosco MC, D\u2019Orazi G. Del Bufalo D Targeting hypoxia in tumor: a new promising therapeutic strategy. J Exp Clin Cancer Res. 2020. https:\/\/doi.org\/10.1186\/s13046-019-1517-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"2461_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.01.001","author":"A Queen","year":"2022","unstructured":"Queen A, Bhutto HN, Yousuf M, Syed MA, Hassan MI. Carbonic anhydrase IX: a tumor acidification switch in heterogeneity and chemokine regulation. Semin Cancer Biol. 2022. https:\/\/doi.org\/10.1016\/j.semcancer.2022.01.001.","journal-title":"Semin Cancer Biol"},{"key":"2461_CR35","doi-asserted-by":"publisher","DOI":"10.1113\/jp278810","author":"P Vaupel","year":"2021","unstructured":"Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol. 2021. https:\/\/doi.org\/10.1113\/jp278810.","journal-title":"J Physiol"},{"key":"2461_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217977","author":"HY Tsai","year":"2025","unstructured":"Tsai HY, Chen MH, Yun J, Lai LA, Valentine JF, Bronner MP, et al. Restricting metabolic plasticity enhances stress adaptation through the modulation of PDH and HIF1A in TRAP1-depleted colon cancer. Cancer Lett. 2025. https:\/\/doi.org\/10.1016\/j.canlet.2025.217977.","journal-title":"Cancer Lett"},{"key":"2461_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022. https:\/\/doi.org\/10.1186\/s12943-022-01530-y.","journal-title":"Mol Cancer"},{"key":"2461_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121110","author":"B Niu","year":"2021","unstructured":"Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X, et al. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121110.","journal-title":"Biomaterials"},{"key":"2461_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115329","author":"G Li","year":"2022","unstructured":"Li G, Lin SS, Yu ZL, Wu XH, Liu JW, Tu GH, et al. A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer. Biochem Pharmacol. 2022. https:\/\/doi.org\/10.1016\/j.bcp.2022.115329.","journal-title":"Biochem Pharmacol"},{"key":"2461_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01800-y","author":"S Zhan","year":"2022","unstructured":"Zhan S, Lu L, Pan SS, Wei XQ, Miao RR, Liu XH, et al. Targeting NQO1\/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth. Br J Cancer. 2022. https:\/\/doi.org\/10.1038\/s41416-022-01800-y.","journal-title":"Br J Cancer"},{"key":"2461_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112746","author":"SH Mun","year":"2023","unstructured":"Mun SH, Lee CS, Kim HJ, Kim J, Lee H, Yang J, et al. Marchf6 E3 ubiquitin ligase critically regulates endoplasmic reticulum stress, ferroptosis, and metabolic homeostasis in POMC neurons. Cell Rep. 2023. https:\/\/doi.org\/10.1016\/j.celrep.2023.112746.","journal-title":"Cell Rep"},{"key":"2461_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-023-2425-2","author":"X Fan","year":"2024","unstructured":"Fan X, Liu F, Wang X, Wang Y, Chen Y, Shi C, et al. LncFASA promotes cancer ferroptosis via modulating PRDX1 phase separation. Sci China Life Sci. 2024. https:\/\/doi.org\/10.1007\/s11427-023-2425-2.","journal-title":"Sci China Life Sci"},{"key":"2461_CR43","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2023.5272","author":"LH Shao","year":"2023","unstructured":"Shao LH, Zhu L, Wang M, Ning Y, Chen FQ, Gao XQ, et al. Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review). Int J Mol Med. 2023. https:\/\/doi.org\/10.3892\/ijmm.2023.5272.","journal-title":"Int J Mol Med"},{"key":"2461_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56711-2","author":"A Gollowitzer","year":"2025","unstructured":"Gollowitzer A, Pein H, Rao Z, Waltl L, Bereuter L, Loeser K, et al. Attenuated growth factor signaling during cell death initiation sensitizes membranes towards peroxidation. Nat Commun. 2025. https:\/\/doi.org\/10.1038\/s41467-025-56711-2.","journal-title":"Nat Commun"},{"key":"2461_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12949","author":"N Nakada","year":"2020","unstructured":"Nakada N, Mikami T, Horie K, Nagashio R, Sakurai Y, Sanoyama I, et al. Expression of CA2 and CA9 carbonic anhydrases in ulcerative colitis and ulcerative colitis-associated colorectal cancer. Pathol Int. 2020. https:\/\/doi.org\/10.1111\/pin.12949.","journal-title":"Pathol Int"},{"key":"2461_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5562","author":"M Qin","year":"2023","unstructured":"Qin M, Liu Q, Yang W, Wang Q, Xiang Z. IGFL2-AS1-induced suppression of HIF-1\u03b1 degradation promotes cell proliferation and invasion in colorectal cancer by upregulating CA9. Cancer Med. 2023. https:\/\/doi.org\/10.1002\/cam4.5562.","journal-title":"Cancer Med"},{"key":"2461_CR47","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-15-0822","author":"KE Lee","year":"2016","unstructured":"Lee KE, Spata M, Bayne LJ, Buza EL, Durham AC, Allman D, et al. Hif1a deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia. Cancer Discov. 2016. https:\/\/doi.org\/10.1158\/2159-8290.Cd-15-0822.","journal-title":"Cancer Discov"},{"key":"2461_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107192","author":"J Debnath","year":"2024","unstructured":"Debnath J, Keshamasetthy D, Combs J, Leon K, Vullo D, Chatterjee A, et al. A comparative study of diaryl urea molecules with and without sulfonamide group on carbonic anhydrase IX and XII inhibition and its consequence on breast cancer cells. Bioorg Chem. 2024. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107192.","journal-title":"Bioorg Chem"},{"key":"2461_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-022-00279-8","author":"M Zatovicova","year":"2022","unstructured":"Zatovicova M, Kajanova I, Barathova M, Takacova M, Labudova M, Csaderova L, et al. Novel humanized monoclonal antibodies for targeting hypoxic human tumors via two distinct extracellular domains of carbonic anhydrase IX. Cancer Metab. 2022. https:\/\/doi.org\/10.1186\/s40170-022-00279-8.","journal-title":"Cancer Metab"},{"key":"2461_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01952-w","author":"Y Wang","year":"2024","unstructured":"Wang Y, Buck A, Piel B, Zerefa L, Murugan N, Coherd CD, et al. Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects. Mol Cancer. 2024. https:\/\/doi.org\/10.1186\/s12943-024-01952-w.","journal-title":"Mol Cancer"},{"key":"2461_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2021.11.018","author":"C Zhang","year":"2022","unstructured":"Zhang C, Fang L, Wang X, Yuan S, Li W, Tian W, et al. Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma. Molecul Therapy - Oncolytics. 2022. https:\/\/doi.org\/10.1016\/j.omto.2021.11.018.","journal-title":"Molecul Therapy - Oncolytics"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02461-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02461-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02461-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:28:42Z","timestamp":1782307722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02461-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":51,"alternative-id":["2461"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02461-x","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"20 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Peking University Shougang Hospital Medical Ethics Committee (IRBK-2022\u2013028-01) on June 8th, 2022. Informed consent was obtained for experimentation with human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}